Articles

  • Aug 6, 2024 | ausdoc.com.au | Kemal Atlay

    Thousands of Australians with advanced lung and liver cancer can now access subsidised subcutaneous immunotherapy that cuts treatment time to seven minutes. On 1 August, Roche’s subcutaneous formulation of atezolizumab (Tecentriq SC) became the first such programmed death-ligand 1 immunotherapy on the PBS. × If this is your first visit to the new AusDoc website, reset your password here.

  • Aug 1, 2024 | ausdoc.com.au | Kemal Atlay

    This Indonesian man’s lower back pain foreshadowed a more sinister diagnosis, with his doctors finding a rare, aggressive form of bone cancer infiltrating his soft tissue. The 50-year-old originally presented in 2021 with a six-month history of lower-left back pain that had gradually limited his activity. × If this is your first visit to the new AusDoc website, reset your password here. Remember MeForgot Password? Having trouble logging in? Back to sign in

  • Jul 29, 2024 | ausdoc.com.au | Kemal Atlay

    Adults who have received an indicated varicella vaccine should be eligible for the recombinant herpes zoster vaccine Shringrix, according to ATAGI. The Australian Immunisation Handbook currently recommends against administering both vaccines — except for in patients who have received a varicella vaccine against its indications. × If this is your first visit to the new AusDoc website, reset your password here. Remember MeForgot Password? Having trouble logging in? Back to sign in

  • Jul 25, 2024 | ausdoc.com.au | Kemal Atlay

    A professional basketballer who sustained an open, fracture-free ankle dislocation during a game returned to the court at the top of his game just three months later, Japanese doctors say. The injury’s rarity — dislocation without accompanying fracture accounts for just 0.46% of ankle dislocations — means there is no consensus on optimal treatment. × If this is your first visit to the new AusDoc website, reset your password here. Remember MeForgot Password? Having trouble logging in?

  • Jul 21, 2024 | ausdoc.com.au | Kemal Atlay

    Endometriosis is linked to a more than fourfold higher risk of ovarian cancer, suggests a US population-based study of nearly half a million women. Researchers identified an even higher cancer risk, almost 10-fold, in women with more severe disease subtypes, such as deep infiltrating endometriosis and ovarian endometriomas. × If this is your first visit to the new AusDoc website, reset your password here. Remember MeForgot Password? Having trouble logging in? Back to sign in

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

X (formerly Twitter)

Followers
2K
Tweets
76K
DMs Open
Yes
No Tweets found.